4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-013725
Vice Chairman & COO bought 21,100 shares at an average $1.49 ($31,463)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEE WILLIS C Vice Chairman & COO | 2022-02-22 | Purchase | +500 | $1.42 | $710 | 256,774 | D |
| LEE WILLIS C Vice Chairman & COO | 2022-02-24 | Purchase | +5,900 | $1.44 | $8,496 | 262,674 | D |
| LEE WILLIS C Vice Chairman & COO | 2022-02-28 | Purchase | +7,200 | $1.51 | $10,872 | 269,874 | D |
| LEE WILLIS C Vice Chairman & COO | 2022-02-28 | Purchase | +6,600 | $1.50 | $9,900 | 234,994 | I |
| LEE WILLIS C Vice Chairman & COO | 2022-02-28 | Purchase | +900 | $1.65 | $1,485 | 1,900 | I |
| Open-market purchases · 21,100 sh · avg $1.49 · $31,463 | |||||||
Loading xslF345X03/doc4.xml…